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Self-Reported Sleep Duration, Napping, and Incident Heart
Failure: Prospective Associations in the British Regional Heart
Study
S. Goya Wannamethee, PhD,* Olia Papacosta, MSc,* Lucy Lennon, MSc,* and
Peter H. Whincup, PhD†
OBJECTIVES: To examine the associations between self-
reported nighttime sleep duration and daytime sleep and
incident heart failure (HF) in men with and without preex-
isting cardiovascular disease (CVD).
DESIGN: Population-based prospective study.
SETTING: General practices in 24 British towns.
PARTICIPANTS: Men aged 60–79 without prevalent HF
followed for 9 years (N = 3,723).
MEASUREMENTS: Information on incident HF cases
was obtained from primary care records. Assessment of
sleep was based on self-reported sleep duration at night
and daytime napping.
RESULTS: Self-reported short nighttime sleep duration
and daytime sleep of longer than 1 hour were associated
with preexisting CVD, breathlessness, depression, poor
health, physical inactivity, and manual social class. In all
men, self-reported daytime sleep of longer than 1 hour
duration was associated with significantly greater risk of
HF after adjustment for potential confounders (adjusted
hazard ratio (aHR) = 1.69, 95% CI = 1.06–2.71) than in
those who reported no daytime napping. Self-reported
nighttime sleep duration was not associated with HF risk
except in men with preexisting CVD (<6 hours:
aHR = 2.91, 95% CI = 1.31–6.45; 6 hours: aHR = 1.89,
95% CI = 0.89–4.03; 8 hours: aHR = 1.29, 95%
CI = 0.61–2.71; ≥9 hours: aHR = 1.80, 905% CI = 0.71–
4.61 vs nighttime sleep of 7 hours). Snoring was not asso-
ciated with HF risk.
CONCLUSION: Self-reported daytime napping of longer
than 1 hour is associated with greater risk of HF in older
men. Self-reported short sleep (<6 hours) in men with
CVD is associated with particularly high risk of developing
HF. J Am Geriatr Soc 2016.
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Numerous prospective studies and meta-analyses ofobservational studies have implicated sleep duration
in the development of cardiovascular disease (CVD); short
or long sleep duration or both have been associated with
greater risk of CVD.1–4 Complaints of sleep difficulty are
common in elderly adults.5 Daytime sleepiness that leads
to napping is common in elderly adults, reflecting changes
in sleep efficiency, sleep quality, and circadian sleep–wake
cycles.6 Daytime sleepiness or excessive daytime napping
has been associated with CVD in middle-aged and older
populations.7–12 Sleep disruptions are common in individu-
als with heart failure (HF), which may result in excessive
sleepiness during the daytime,13 but prospective studies on
the relationship between sleep duration and daytime nap-
ping and sleepiness and incident HF in people without HF
are limited. Although three studies have shown daytime
sleepiness or insomnia symptoms to be associated with
greater HF risk,7,14,15 two other studies showed no associ-
ation between sleep duration and HF risk.3,16 Although
previous research has suggested that impaired sleep may
also affect prognosis after CVD,17,18 the association
between sleep duration and daytime sleep with risk of HF
specifically in those with a history of CVD has been little
studied. The current study examined the association
between self-reported sleep duration, daytime sleep, and
risk of incident HF in a cohort study of older British men
with and without preexisting CVD.
SUBJECTS AND METHODS
The British Regional Heart Study is a prospective study of
CVD involving 7,735 men aged 40–59 selected from the
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age and sex registers of one general practice in each of 24
British towns and screened between 1978 and 1980.19 In
1998–2000, all surviving men (N = 5,447), now aged 60–
79, were invited for a 20-year follow-up examination;
4,252 (77% of survivors) attended. All relevant local
research ethics committees provided ethical approval. All
men provided informed written consent to the investiga-
tion, which was conducted in accordance with the Decla-
ration of Helsinki. In 2003, a postal questionnaire was
sent to all survivors, then aged 63–82, that asked for infor-
mation on medical history, lifestyle changes, and sleep
habits; 3,982 men responded (81% response rate). Of
these, 259 with a history of a doctor diagnosis of HF were
excluded, leaving 3,723 for analysis.
Cardiovascular Risk Factors and Morbidity
In the 2003 questionnaire, detailed questions were asked
on smoking habits, physical activity, and body weight.20
Participants were classified into manual and nonmanual
workers based on the longest-held occupation of subjects
at study entry using the Registrar General Social Class
Classification. Body mass index (BMI) was calculated as
body weight divided by height squared (kg/m2). Height
was extrapolated from height measured during the physi-
cal examination in 1998–2000. Subjects were asked to
report a doctor diagnosis of heart attack, stroke, heart fail-
ure, depression, high blood pressure, or high blood choles-
terol and to report symptoms of breathlessness and
treatment to lower blood pressure. They were also asked
to describe their health status as excellent, good, fair, or
poor.
Self-Reported Sleep
In the 2003 questionnaire, self-reported nighttime sleep
duration and daytime sleep were determined based on
answers to the questions: “On average how many hours
sleep do you have each night?” and “On average how
much sleep do you have during the daytime?” The men
responded with duration of sleep in hours and minutes.
They were also asked whether they snored (yes regularly,
yes occasionally, no, don’t know).
Follow-Up
All men have been followed from initial examination
(1978–1980) for cardiovascular morbidity 21 and all-cause
mortality, with near-complete follow-up (99%) of the
cohort for morbidity and mortality. In the present analy-
ses, all-cause mortality and morbidity events are based on
9 years of follow-up from 2003–2012. Mortality data was
collected through the established “tagging” procedures
that the National Health Service registers provide. Nonfa-
tal myocardial infarction (MI) was diagnosed according to
World Health Organization criteria. Evidence of nonfatal
MI and HF was obtained according to ad hoc reports from
general practitioners supplemented by biennial reviews of
practice records (including hospital and clinic correspon-
dence) to the end of the study period. Incident nonfatal
HF was based on a confirmed doctor diagnosis of HF from
primary care records and where possible verified using
details of available clinical information from primary and
secondary care records (including symptoms, signs, investi-
gations, and treatment response) to ensure that the diagno-
sis was consistent with current recommendations on HF
diagnosis.22 Incident HF included incident nonfatal HF
and death from HF as the underlying cause (International
Classification of Diseases, Ninth Revision, code 428).
Statistical Methods
Nighttime sleep duration was categorized into five groups
(<6, 6, 7, 8, ≥9 hours; 7 hours was used as the reference
group. Daytime napping was categorized into four groups
(none, <1, 1, >1 hour). Cox proportional hazards models
were used to assess hazard ratios (HRs) (relative risk),
adjusting for factors known to be associated with HF risk,
including smoking (never, ex, current), social class (man-
ual, nonmanual), physical inactivity (yes, no), previous MI
(yes, no), stroke (yes, no), diabetes mellitus (yes, no), use
of antihypertensive treatment (yes, no), breathlessness (yes,
no), BMI, and poor health (yes, no). To assess whether the
association between duration of sleep and daytime sleep
and incident HF may be due to the development of inci-
dent MI, incident CHD was adjusted for by fitting CHD
as a time-dependent covariate. Subsidiary analyses were
performed stratified according to preexisting doctor-diag-
nosed CVD (MI, stroke). All analyses were performed
using SAS version 9.3 (SAS Institute, Inc., Cary, NC).
RESULTS
During the follow-up of 9 years, there were 199 incident
HF cases (rate 7.3/1,000 person-years) in the 3,723 men
with no diagnosed HF. Meanstandard deviation reported
nighttime sleep in the study was 7.0  1.3 hours.
Baseline Characteristics According to Self-Reported
Sleep Variables
Men who reported 7–8 hours of sleep generally had the
lowest prevalence of adverse risk factors. Men who
reported short sleep duration (<6 hours) had by far the
highest prevalence of poor health, preexisting CVD,
breathlessness, and history of depression (Table 1). Those
who reported long sleep duration (≥9 hours) also had high
rates of preexisting CVD. Men who reported daytime nap-
ping of longer than 1 hour had the highest prevalence of
adverse risk factors and ill health. These men were also
more likely to report short sleep duration at night and reg-
ular snoring.
Self-Reported Sleep Duration, Daytime Sleep, and
Incident HF
Only self-reported short nighttime sleep was associated
with greater risk of HF, although this was largely due to
adverse characteristics associated with short sleep because
adjustment for age, social class, BMI, smoking, diabetes
mellitus, physical activity, treated hypertension, breathless-
ness, preexisting CVD, and poor health attenuated the
association (Table 2). Self-reported daytime napping of
longer than 1 hour was associated with significantly
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greater risk of HF that remained even after adjustment for
the above potential confounders. When stratified according
to preexisting CVD status, no association was found
between sleep duration and HF risk in those with no his-
tory of CVD (Table 3), although in men with preexisting
CVD, a significant U-shaped association was observed,
with short and long sleep associated with greater HF risk
even after adjustment for potential confounders (quadratic
trend P = .03). Daytime napping of longer than 1 hour
was associated with greater risk of HF particularly in men
without CVD. This persisted even after taking into
account incident CHD. Self-reported regular snoring was
not associated with risk of HF in either group.
The association between self-reported daytime napping
and HF risk was largely seen in obese men (BMI ≥30.0 kg/
m2) (adjusted HR (aHR) = 4.27, 95 CI = 1.58–11.59). No
association was found in nonobese men (aHR = 1.27,
95% CI = 0.73–2.22; P = .008).
DISCUSSION
In this study of older British men, only reported excessive
daytime sleeping (>1 hour), which was prevalent in 7% of
the men, was associated with significantly greater risk of
HF than not napping; this was seen particularly in men
without preexisting CVD and in obese men. Self-reported
nighttime sleep duration was associated with HF only in
men with preexisting CVD. There was no association
between self-reported habitual snoring and HF, which is
consistent with findings of other studies.7,18 The findings
of the current study support and extend the findings of
previous studies that have implicated daytime sleepiness7
and sleep disturbance in HF.14,15
Self-Reported Nighttime Sleep Duration and HF
No association was found between self-reported nighttime
sleep duration and HF in the overall population, which is
consistent with findings from two other large studies of
men and women,3,16 although in men with CVD, a
U-shaped relationship was seen, with short sleep in partic-
ular and to a lesser extent long nighttime sleep related to
greater HF risk. No association was seen in the larger
group of men without CVD. Obstructive sleep apnea
(OSA), which is common in individuals with CVD, is a
major cause of sleep disturbance and short sleep23 and has
been linked to incident HF.24 The higher risk of HF associ-
ated with short sleep in men with preexisting CVD may
reflect the high rates of OSA. Short sleep duration after
MI may also be a consequence of more-severe underlying
cardiac dysfunction leading to hypoxia and greater risk of
HF. Long nighttime sleep duration in men with preexisting
CVD may be a consequence of the coexistence of a num-
ber of comorbidities such as chronic kidney disease and
Table 2. Self-Reported Nighttime Sleep Duration,
Daytime Napping, Snoring, and Risk of Incident Heart
Failure in Older Men with No History of Doctor-Diag-
nosed Heart Failure
Factor n
Rate/1,000
Person-
Years (n)
Hazard Ratio (95%
Confidence Interval)
Age
Adjusted Adjusteda
Self-reported nighttime sleep duration, hours
<6 348 9.7 (25) 1.53 (0.95–2.45) 1.26 (0.77–2.05)
6 767 7.4 (45) 1.16 (0.78–1.72) 1.09 (0.73–1.63)
7 1,064 6.1 (53) 1.00 1.00
8 1,188 5.8 (55) 0.92 (0.63–1.34) 0.89 (0.61–1.29)
≥9 281 8.1 (17) 1.19 (0.69–2.06) 1.07 (0.62–1.86)
Self-reported daytime napping, hours
0 1,889 5.7 (88) 1.00 1.00
<1 679 5.9 (33) 0.94 (0.63–1.41) 0.95 (0.63–1.42)
1 869 8.3 (55) 1.30 (0.93–1.83) 1.18 (0.84–1.66)
>1 286 12.4 (23) 1.99 (1.25–3.15) 1.69 (1.06–2.71)
Self-reported snoring
No 462 8.0 (28) 1.00 1.00
Occasionally 1,868 5.8 (88) 0.75 (0.55–1.02) 0.76 (0.55–1.04)
Regularly 717 6.3 (37) 0.89 (0.60–1.33) 0.82 (0.55–1.23)
Data on nighttime sleep duration were not available in 75 men. Data on
snoring were not available in 90 men, who were excluded from the analy-
sis on snoring.
aAdjusted for age, type of work, body mass index, smoking, diabetes mel-
litus, physical activity, treated hypertension, breathlessness, preexisting
myocardial infarction, stroke, poor health.
Table 3. Self-Reported Nighttime Sleep Duration,
Daytime Napping, and Risk of Incident Heart Failure
in Older Men with and without Preexisting Cardiovas-
cular Disease (CVD; Myocardial Infarction or Stroke)
Factor
Rate/1,000
Person-
Years (n)
Hazard Ratio (95% Confidence
Interval)
Age
Adjusted Adjusteda
No preexisting CVD (n = 3,066)
Self-reported nighttime sleep duration, hours
<6 (n = 265) 5.9 (12) 1.00 (0.53–1.91) 0.77 (0.40–1.51)
6 (n = 637) 5.6 (29) 0.97 (0.60–1.56) 0.86 (0.53–1.40)
7 (n = 888) 5.5 (41) 1.00 1.00
8 (n = 1,000) 4.7 (38) 0.82 (0.53–1.27) 0.77 (0.49–1.19)
≥9 (n = 219) 5.9 (10) 0.94 (0.47–1.88) 0.85 (0.42–1.70)
Self-reported daytime napping, hours
0 (n = 1592) 4.5 (59) 1.00 1.00
<1 (n = 565) 3.8 (18) 0.79 (0.47–1.34) 0.79 (0.45–1.35)
1 (n = 692) 7.2 (39) 1.46 (0.97–2.20) 1.31 (0.87–1.98)
>1 (n = 217) 10.8 (16) 2.22 (1.28–3.86) 1.79 (1.01–3.17)
Preexisting CVD (n = 657)
Self-reported nighttime sleep duration, hours
<6 (n = 83) 23.9 (13) 2.76 (1.26–6.06) 2.91 (1.31–6.45)
6 (n = 130) 17.2 (16) 1.82 (0.86–3.85) 1.89 (0.89–4.03)
7 (n = 176) 9.4 (12) 1.00 1.00
8 (n = 188) 12.6 (17) 1.29 (0.63–2.71) 1.29 (0.61–2.71)
≥9 (n = 62) 17.7 (7) 1.87 (0.74–4.76) 1.80 (0.71–4.61)
Self-reported daytime napping, hours
0 (n = 297) 13.5 (29) 1.00 1.00
<1 (n = 114) 17.3 (15) 1.16 (0.62–2.17) 1.16 (0.61–2.20)
1 (n = 177) 13.3 (16) 0.90 (0.49–1.66) 0.88 (0.47–1.64)
>1 (n = 69) 19.0 (7) 1.40 (0.61–3.20) 1.35 (0.58–3.10)
Data on nighttime sleep duration were not available in 75 men.
aAdjusted for age, social class, body mass index, smoking, physical activ-
ity, diabetes mellitus, treated hypertension, breathlessness, and poor
health.
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stroke, which puts these men at higher risk of HF, or it
may reflect depression, which has been linked to HF
risk.25
Self-Reported Daytime Sleep and HF
Self-reported daytime sleep of longer than 1 hour was
associated with shorter nighttime sleep, obesity, depres-
sion, breathlessness, prevalent CVD, and overall ill health,
although the association between self-reported daytime
sleep and HF was seen particularly in those with no CVD
and after adjustment for these factors. These findings are
consistent with those reported in the Cardiovascular
Health Study, which found daytime sleepiness to be associ-
ated with HF.7 In contrast, in a Japanese cohort study,
daytime napping (yes, no) was not associated with HF
after adjustment for confounders, although duration of
daytime napping was not examined.8
The association between daytime sleep and HF could
reflect insufficient sleep or disturbed sleep,6 which have
been associated with HF risk,14,15 although short nighttime
sleep duration, which is a characteristic of insomnia, was
not associated with HF in men without CVD, in whom
daytime napping was more strongly associated with HF
risk. The Cardiovascular Health Study found daytime
sleepiness but not actual sleep disturbance to be associated
with HF.7 Another possible explanation for the relation-
ship between daytime sleep and HF may be OSA, which is
commonly associated with snoring and daytime sleepi-
ness.23 Obesity is a major correlate of OSA, and the find-
ing that daytime sleep was associated with HF only in
obese men is consistent with this explanation.
Strengths and Limitations
The strengths of the study include a study population
socially representative of the United Kingdom and the
exceptionally high follow-up rates in the British Regional
Heart Study. There are several limitations of this study. It
is based on a cohort of older (60–79) men, and the results
need further confirmation in women and other older and
middle-aged populations. The findings are based on self-
reported sleep patterns measured at one point only, and
the possibility cannot be excluded that nighttime sleep
duration and time spent daytime napping may have been
misclassified, raising the possibility that the strength of the
associations between sleep duration, napping, and HF have
been underestimated. It is not known whether the daytime
napping was voluntary, but self-reported daytime napping
of longer than 1 hour per day has been shown to be asso-
ciated with markedly greater mortality.26 Information was
not available on time spent in bed, but the average self-
reported nighttime sleep of 7 hours in this study is compa-
rable with the findings of another UK population study of
older adults that reported 6.9 hours average sleep.27
Nighttime sleep duration was based on average duration
of nighttime sleep; no measures of nighttime sleep inter-
ruptions or information on sleep apnea and insomnia,
which could affect sleep duration and influence HF risk,
were available. The current findings are based on doctor-
diagnosed HF, which is likely to underestimate the true
incidence of HF in this study population, although the
determinants of this HF outcome in this study population
(including obesity, N-terminal of the prohormone brain
natriuretic peptide, social class)28–30 generally accord with
prior data and suggest that the HF outcome used was
valid.
CONCLUSION
Self-reported daytime sleep of longer than 1 hour is associ-
ated with significantly greater risk of HF in older men.
These findings point to the need for healthcare providers
to discuss daytime sleep patterns with older adults. In men
with CVD, self-reported short nighttime sleep in particular
is associated with greater risk of developing HF. Evalua-
tion of sleep disturbances in older men with CVD may
identify treatable conditions such as sleep apnea, cardiac
dysfunction, or depression, which have potential implica-
tions for HF prevention.
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